Navigation Links
Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools
Date:8/27/2009

BOSTON, Massachusetts and CHEADLE, England, August 27 /PRNewswire/ -- Cardea Technology, Inc. and Optasia Medical Ltd., announce plans to collaborate and configure their software tools for Vertebral Fracture Assessment, a method for evaluating vertebral fractures from images on bone densitometers, to exchange information and create reports for the management of osteoporosis.

Optasia Medical Ltd. has developed SpineAnalyzer(TM), a product that aids in the identification of vertebral spine deformities by efficiently and comprehensively annotating spine anatomy. This unique software workflow solution enables rapid and reproducible assessment of 6-point morphometry, while simultaneously providing full contours outlining vertebral shape. The software employs a proprietary statistical model-based image analysis technique, which uses a simple manual single-point initialization to automatically segment the lateral vertebrae from T4 to L4. SpineAnalyzer(TM) is designed to fit seamlessly into the existing workflow of scoring a lateral spine image.

Cardea Technology develops BoneStation, a web-based software program that automates the review of VFA and X-Ray scans and the creation of bone density reports. BoneStation facilitates the secure transmission of DXA scans and data from a bone densitometer to a central database where scans are instantly viewed from any computer with internet access. During the scan review in BoneStation, a physician can incorporate a patient's bone fracture risk factors into the patient's overall assessment and report.

With new data sharing functions, BoneStation and SpineAnalyzer(TM) provide physicians with enhanced capability to measure and report on vertebral spine deformities. After an operator creates a 6-point morphometry assessment with SpineAnalyzer(TM), it is displayed in the BoneStation interface and integrated into BoneStation's comprehensive osteoporosis assessment reports.

For more information and a tour of BoneStation's capabilities, please visit http://www.bonestation.com. For more information on Optasia Medical and SpineAnalyzer(TM), please visit http://www.optasiamedical.com. SpineAnalyzer(TM) is pending FDA approval and is not currently available for sale in the US.

Contact: Peter Steiger +1-508-405-4392 & Gretchen DeGlopper +1-877-392-7763 ext 504


'/>"/>
SOURCE Cardea Technology Inc. and Optasia Medical Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Novel Technology Breaks Through Cancer Pain
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Advanced Cell Technology Announces Proposed Financing
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
10. China Technology Announces New Chief Financial Officer
11. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage ... drug delivery systems, announced today that Dr. ... deliver a presentation titled, "Oral Insulin for Diabetes ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference ...
(Date:3/22/2017)... ALBANY, New York , March 22, 2017 /PRNewswire/ ... market is largely fragmented, states a research report by ... Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., ... market in 2015. The prominent players in this market ... to expand their product portfolio, which is likely to ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT announced ... "Company" or "Propellon"), a start-up created by FACIT ... therapeutics. FACIT,s investment, combined with non-dilutive capital, achieves ... The seed funding enables Propellon to accelerate the ... Company for financing and/or entering a strategic partnership ...
(Date:3/22/2017)... 2017   VWR (NASDAQ: VWR), ... and service solutions to laboratory and production ... EPL Archives, Inc., an international biorepository services ... regulated product research, development and commercialization lifecycle ... ancillary services. EPL Archives is widely recognized ...
Breaking Biology Technology:
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/9/2017)... MELBOURNE , Australia , March ... clinical study data at the prestigious World Lung Imaging ... Dr. Andreas Fouras , was invited to deliver ... and pulmonary medicine. This globally recognised event brings together ... and share the latest developments in lung imaging. ...
(Date:3/6/2017)... 2017 Mintigo , the leader ... Predictive Sales Coach TM , its new artificial ... into Salesforce. This unique AI application will allow ... with deep knowledge of their customers and prospects ... Predictive Sales Coach extends Mintigo,s existing customer success ...
Breaking Biology News(10 mins):